Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | SLC13A5 | Q86YT5 | 1/20 | 0.62 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8372164 | 0.87 | MEN1 (0.61) | ALDH1A1KMT2APOLBMEN1 | |
| SCHEMBL12993901 | 0.87 | ALDH1A1 (0.67) | ALDH1A1KMT2ACA12CA1CA2 | |
| SCHEMBL11296859 | 0.86 | MAPT (0.68) | ALDH1A1KMT2ASLC13A5POLBMEN1 | |
| SCHEMBL13745563 | 0.86 | ALDH1A1 (0.67) | ALDH1A1KMT2ASLC13A5POLBCA12 | |
| SCHEMBL13746186 | 0.85 | NPSR1 (0.72) | ALDH1A1EPHX2POLB | |
| SCHEMBL24423083 | 0.84 | KMT2A (0.63) | KMT2APOLBMEN1 | |
| SCHEMBL7486412 | 0.84 | ALDH1A1 (0.58) | ALDH1A1KMT2ASLC13A5EPHX2POLB | |
| SCHEMBL13745506 | 0.83 | ALDH1A1 (0.70) | ALDH1A1POLB | |
| SCHEMBL13746194 | 0.83 | POLB (0.62) | ALDH1A1KMT2APOLB | |
| SCHEMBL7844706 | 0.83 | ALDH1A1 (0.63) | ALDH1A1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009098282-A1 | LOW MOLECULAR WEIGHT 2,5-DISUBSTITUTED THIOPHENE DERIVATIVES AND USE THEREOF IN THERAPY | NOVASAID AB (SE) | 2009-08-13 | — | — | WO | disclosed |